Explore funding opportunities dedicated to driving healthcare innovation. Whether you're developing groundbreaking solutions or leading collaborative research projects, our funding directory highlights valuable support to help bring your ideas to life.
The list below provides an overview of current funding opportunities and is updated regularly. Please note, this is not an exhaustive directory and only highlights a selection of available calls.
Our funding team has access to a comprehensive global database of funding calls and initiatives. If you're seeking a more extensive and tailored search to find the right opportunities for your innovation, we’re here to help.
Contact us at fundingsupport@lshubwales.com for guidance, bid review and editing, and help finding the perfect opportunity for your project. Last updated: November 2025
The NIHR Public Health Research (PHR) Rapid Funding Scheme supports urgent, small-scale baseline data collection or feasibility studies for non-NHS public health interventions. Aimed at time-sensitive opportunities like natural experiments, projects must demonstrate urgency, align with PHR goals, and lead to a full evaluation proposal with potential to inform public health policy.
The NIHR HTA Call 2025/375 invites proposals evaluating the clinical and cost-effectiveness of ambulance service led interventions, including those delivered by air ambulance teams. Interventions should be managed by professionals such as paramedics or urgent care clinicians, with applications encouraged across a wide range of urgent, emergency, and critical care settings.
The NIHR HTA Call 2025/375 invites proposals evaluating the clinical and cost-effectiveness of ambulance service led interventions. Areas of interest include pain management, falls, mental health, infection control, palliative care, maternity, and safe non-conveyance. Studies must focus on patient-centred outcomes, not service delivery or implementation issues.
NIH Small Grant Programme (R03) funding supports small medical research projects that can be carried out in a short period of time with limited resources. Examples of the types of projects supported under the R03 mechanism include:
Pilot or feasibility studies, Secondary analysis of existing data, Small, self-contained research projects, Development of research methodology, Development of new research technology.
This Funding Opportunity Announcement (FOA) supports discrete, well-defined projects in any area of cancer research using the National Institutes of Health R03 small grant mechanism. The National Institutes of Health R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following: Pilot or feasibility studies.Secondary analysis of existing data.Small, self-contained research projects.Development of research methodology.Development of new research technology.
This funding call is aimed at clinical health professionals who are seeking to undertake research to establish or develop a research career and who have the potential to be research leaders of the future. Research should increase understanding of the disease mechanisms underlying cancer pain, particularly leading to better understanding of prevention, treatment or management of cancer pain.
The funding is intended to support partnership proposals spanning arts, health, social care, nature, environment, and the third sectors. Eligible projects should address health challenges and priorities, encompassing areas such as nature, mental health, health inequalities, physical wellbeing, and staff wellbeing within healthcare and the arts sector.
Funding for high-quality applied health and social care research to increase and improve the evidence base about early action and prevention with health and social care services. Improving the population's health, either by preventing illness or identifying the cause of ill health at an early stage, is a key focus to reducing health inequalities and is at the heart of the NHS Long Term Plan.
The NIHR Team Science Award is an annual development award for research teams who are looking to collaborate on a future application to other research programmes, expand their research network, and develop research capacity.
The Dame Josephine Barnes Bursary from POGP supports educational and research efforts in pelvic, obstetric, and gynaecological physiotherapy. It can fund courses, international travel to promote women’s health, or serve as seed funding for Patient and Public Involvement and Engagement (PPIE) in research. Open to UK-based applicants and international initiatives.
The Urology Foundation promotes and supports research and education for the better treatment, diagnosis and prevention of all urological conditions. These include cancer and diseases of the prostate, kidney, bladder and testes, male infertility, erectile dysfunction and incontinence.
Friends for an Earlier Breast Cancer Test (Earlier.org) is a US-based non-profit organisation, established in 1995, that is dedicated exclusively to funding research focused on developing innovative methods for the earlier detection of breast cancer. Its mission is to support the creation of a biological test capable of identifying breast cancer at its earliest stages, potentially even before a tumour has formed. Earlier.org provides funding to support pilot projects that explore new techniques for early breast cancer detection. Grants are intended to provide preliminary data that can lead to more substantial peer-reviewed funding.
International Grants are available to support dissertation expenses related to research into the effectiveness of the Eye Movement Desensitisation and Reprocessing (EMDR) method for the treatment of trauma.
The RAD Teams awards are designed to enable high-potential leaders to establish an interdisciplinary team of scientists to develop their innovative ideas over a five-year period. The awards will support basic science, translational and clinical research projects in the following areas: Development of new diagnostic tests, strategies for prevention, understanding disease mechanisms, identification and evaluation of potential new treatments.
Funding to establish challenge-led MRC Centres of Research Excellence (CoRE) to tackle complex and interdisciplinary health challenges and train the next generation of researchers and technologists.
Women founders or co-founders of UK registered SMEs can apply for a package of support that includes a grant of up to £75,000 and bespoke business support, to further their ambitious growth plans.
This Notice of Funding Opportunity (NOFO) invites mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including one's response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental and systemic factors. Expectancy effects are the cognitive, behavioural and biological outcomes caused by expectancies. Expectancy effects can be generated by expectancies held by patients, clinicians, family members, caregivers and/or dyadic/social networks.
Knowledge Transfer Partnerships (KTPs) are funded by IUK with the aim of helping businesses innovate and grow. KTPs involve a three-way partnership between a business, an academic institution and a graduate whereby the academic institution employs the recently qualified graduate to work at the company, while the graduate (known as the 'associate') brings new skills and knowledge to the business.
Funding programme to support exploratory drug discovery projects aiming to validate and de-risk targets and accelerate the translation of laboratory discoveries into novel cancer therapeutics.
Wellcome's Doctoral Programmes for Healthcare Professionals initiative funds doctoral programmes to deliver outstanding training in discovery research to registered healthcare professionals in the UK.
Breast Cancer UK is offering funding for projects exploring the relationship between all environmental contaminants that and breast cancer risk. Two avenues of award are available: Career Development Awards (fka Foundation Awards) will support early career researchers (ECRs) working in breast cancer prevention. Applications should focus on environmental contaminants (known or suspected) and breast cancer risk. Alongside the proposed funding for research, Breast Cancer UK will also offer an optional career coaching programme for the duration of the grant. Seed Grants are focused on chemicals and breast cancer risk. Funding can be applied flexibly and can be utilised as a top-up for a project close to completion, to obtain a specific piece of equipment, or to fund a pilot project focused on chemicals and breast cancer risk.
Funding to support projects led by practitioners in local authorities, care providers and community/voluntary organisations. Practitioners will partner with researchers to carry out evaluative projects that test new approaches, frameworks and ideas in their organisations.
The Small Research Grant (R03) programme will support meritorious projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD).
Funding is provided for research teams in the UK to produce high-impact Technology Assessment Reviews (TARs) on drugs, devices, interventional procedures, and diagnostic tests for the NHS.
HABRI advances life-science research on human–animal interaction by funding evidence-based studies on how companion animals influence human health, wellbeing and behaviour. Its programme supports translational, clinically relevant investigations of pet ownership and animal-assisted interventions across diverse populations, species and cultures, generating actionable guidance for healthcare, veterinary and policy stakeholders.
The Daisy Foundation was created in 1999 in memory of Patrick Barnes, to keep his spirit alive and also say a profound thank you to nurses for the extraordinary skill and compassion they provide patients and families every day. Daisy stands for diseases attacking the immune system. Through its Health Equity Grants, the Foundation supports nursing research and evidence-based projects (EBP) with grants to nurses.
Fellowship programme for senior postdoctoral clinical academics in the UK who wish to undertake funded research and take part in a bespoke training and leadership development programme.
Alzheimer's Research UK provides PhD Scholarships to provide a stipend, tuition costs and research/travel costs for a full PhD programme. National or international secondments are supported and encouraged within the scheme.The award is for up to four years and is for the full duration of a PhD programme. Alzheimer's Research UK is open to considering applications for part-time PhD students.
The funding bid supports clinical cancer research projects by academic and non-profit institutions worldwide, focusing on improving patient outcomes, prevention, early detection, and innovative therapies. Eligible projects include interventional clinical trials, early detection studies, and paediatric cancer trials, with mandatory patient involvement. Priority is given to projects showing potential patient impact within five years.
The National Institute for Health and Care Research (NIHR) Climate Change and Health Research Collaboration Awards will support research that addresses the challenges of climate change by building resilience into the delivery of health and social care services during severe weather events (made worse by climate change), for example, extreme heat and flooding.
This opportunity is provided by the Oxford-Harrington Rare Disease Centre (OHC), a partnership between the University of Oxford and Harrington Discovery Institute to advance promising discoveries from academic labs to move them into clinical practice. The award combines funding and expert therapeutics development support to help researchers in the UK, US, or Canada to accelerate preclinical projects towards treatments for patients.
The Oxford–Harrington Rare Disease Scholar Award supports UK-based researchers advancing rare disease discoveries towards clinical impact. Scholars receive £100,000, tailored drug development expertise, and project support. Offered by the Oxford–Harrington Rare Disease Centre, the award also provides access to further funding while allowing researchers to retain full intellectual property rights.
The funding bid is for a Doctoral and Skills Enhancement (DSE) award, supporting early- to mid-career researchers to gain skills and experience for future NIHR personal awards or research grants. It provides salary for up to 2 years, plus training, development, conference, and mentorship costs, but does not fund practice time.
The NIHR Decarbonising the Health and Social Care System funding opportunity will run annually for a period of five years (2024 to 2028), with total funding of £25 million. The aim is to fund research into decarbonising the health and social care system as part of NIHR's climate health and sustainability commitments to help reduce carbon emissions and achieve net zero.
The NIHR Work and Health Research Awards fund large, cross-disciplinary projects tackling key issues like long-term conditions, disability, sickness absence, COVID-19 impact, workforce mental health, and health inequalities. Aimed at improving employment and health outcomes, proposals should involve cross-sector teams, support implementation in systems like ICSs, and deliver public benefit.
Funding to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test or other medical intervention development. This fund will provide small scale funding to generate critical data needed prior to seeking more substantive funding.
The NIHR Work and Health Research Awards support large-scale, ambitious projects addressing key priorities in work and occupational health. Up to £2 million over three years is available for transdisciplinary teams. Applicants should consult the NIHR Work and Health Logic Model to align proposals with the initiative’s short- and long-term aims.
Wellcome's Genomics in Context Awards - Collaborative Research at the Intersection of Genomics, Humanities, Social Sciences and Bioethics scheme will fund transdisciplinary teams to drive research breakthroughs at the crossroads of genomics, humanities, social sciences and bioethics. Supported projects will receive dedicated time and resources to shape fresh research directions and experiment with novel approaches to collaboration. This scheme is expected to open in November 2025.
This call is aimed at supporting novel and transdisciplinary teams to explore this intersection at the earliest stages of research ideation, design and partnership building. Collaborations could take many different forms and centre on a variety of areas of focus.
A very small number of grants are available to UK registered or exempt charities and NHS organisations to expand proven health and care interventions and deliver them more widely within the UK.
Proposals must address the following research question: What is the best step-up treatment for people aged 12 years and older diagnosed with asthma, whose asthma is uncontrolled on a low-dose inhaled corticosteroid/formoterol combination inhaler used as needed?
The funding bid supports research addressing palliative and end-of-life care priorities identified by the James Lind Alliance. It aims to evaluate interventions that enable people to die well at home, support those with multiple conditions, and address the needs of socially isolated individuals. Projects should improve community care, staff and carer skills, care integration, and equitable access to services.
The GOSH Charity National Research Programme Grants provide support for ambitious, long-term research programmes that will generate a significant shift in the progress or understanding within an area of rare or complex paediatric disease.
The CRUK research funding programme awards a wide range of fellowships and grants to support researchers, across all career stages, conducting clinical, pre-clinical, discovery and translational research to advance the detection, diagnosis, treatment, and potential cure, of all forms of cancer.
The CRUK research funding programme awards a wide range of fellowships and grants to support researchers, across all career stages, conducting clinical, pre-clinical, discovery and translational research to advance the detection, diagnosis, treatment, and potential cure, of all forms of cancer.
Funding over a maximum period of ten years to support innovative, investigator-led clinical research - incorporating clinical trials, experimental medicine and sample collection - to further understanding of the biology and treatment of cancer.
Funding over two years for researchers and clinical academics based at institutions in the UK to undertake pilot studies and preliminary research on movement and balance disorders in children and young people.
FSHI's Research Grant Development Awards provide pump-priming funds for the development of high-quality, innovative research in areas of the sociology of health and illness. Grants are intended to support groups to produce substantive outputs in the form of a full grant application to a major national or international funding body and, where appropriate, publications in peer-reviewed journals.
This initiative encourages applications from organisations operating in Wales that have the potential to increase and sustain co-operation with important international regions. This may include relevant bi-lateral agreements or a relevant and specific Welsh Government strategy.
This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.
The funding bid supports small, innovative projects to improve outcomes and patient experience in bladder cancer. It aims to stimulate research and practical initiatives across primary care, clinical, and laboratory settings, focusing on early diagnosis, treatment pathways, patient support, and underrepresented areas, with preference for new or pilot work demonstrating clear, measurable impact.
The FARA Award for Innovative Mindset (AIM) supports the early stage exploration of innovative, high-risk/high-impact and potentially ground-breaking concepts in FA research that will foster new directions, bring new perspectives to the field, and address neglected issues in FA research. Studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is encouraged, but not required.
The funding bid supports the development of a Strategic Research and Innovation Agenda (SRIA) on cardiovascular diseases (CVDs) and related comorbidities in the EU. It aims to map existing research, identify gaps, integrate digital and personalised approaches, address sex-, gender-, and socio-demographic disparities, and guide prevention, early detection, and screening strategies through stakeholder engagement and evidence-based recommendations.
The funding bid supports research on the impact of digital technologies on the mental health of children and young adults. Projects should generate robust neurobiological and behavioral evidence, develop and test innovative digital interventions to promote responsible use, foster resilience, and prevent or mitigate mental disorders, incorporating sex-, gender-, and intersectional analyses, cohort or clinical studies, and end-user involvement.
The funding bid supports research on sex- and gender-specific cardiovascular disease (CVD) mechanisms to improve prevention, diagnosis, and treatment. It aims to develop tailored risk models, identify relevant determinants, exploit existing and new health data, and integrate social, cultural, and digital approaches, enhancing inclusive, innovative, and clinically impactful CVD interventions.
This NIHR funding supports research into community-based interventions to improve veterans’ mental and physical health. It should address challenges of transition, stigma, and access through population-level approaches such as housing, employment, and coordinated care. Robust outcomes, economic evaluation, and stakeholder engagement are essential to inform policy and enhance holistic care.
This NIHR Public Health Research call invites proposals evaluating public mental health interventions to promote wellbeing or prevent mental ill-health in men. It emphasises a life‑course approach, targets health inequalities, encourages community‑level initiatives, and demands economic evaluation and involvement of people with lived experience.
The funding bid supports research evaluating the clinical and cost-effectiveness of ambulation-focused rehabilitation programs for community-dwelling adults post-stroke with impaired walking. The study will assess impacts on quality of life, mental health, gait, mobility, independence, carer outcomes, and cost-effectiveness compared with usual care, considering demographic and regional variations.
Funding for independent scientific research in type 2 inflammation and its associated diseases, including atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyps.
Grants for researchers in Denmark to partner with international researchers to conduct exploratory research projects to develop tools to combat emerging and increasing threats from infectious diseases, including pathogenic fungi, novel antimicrobial resistance (AMR) tools and harnessing innate immunity.
Fellowship funding to enable researchers to visit centres for clinical or diagnostic virology in Europe, with the aim of furthering knowledge in clinical or diagnostic virology.
The Foundation's Conference Awards for Ageing Research support allied health professionals, nurses and pharmacists who are actively involved in ageing-related research and wish to disseminate their findings at national or international conferences. The aim is to support early career researchers who do not have access to conference funds through existing grants or fellowships.
The NIAAA invites applications for research projects focused on closing the treatment gap for alcohol use disorder (AUD). Priorities include improving access, appeal, and implementation of treatments, analysing cost and insurance systems, and addressing health disparities. Projects may span multiple disciplines, with up to five years’ funding.
The National Cancer Institute (NCI) intends to stimulate research in discovery and development of novel, small molecules for cancer. Molecules discovered may be used to probe cancer biology, to validate cancer targets or as the basis for optimised drugs.
This funding opportunity supports developing data and metadata standards for wearable technology to improve mental health research. Recipients will collaborate with manufacturers, researchers, and ethics experts to enable data integration, like DICOM for imaging. Funding depends on NIH budgets; projects may last up to four years with no budget cap.
Fellowship scheme for early career researchers and innovators looking to establish or transition to independence, or to develop their own ambitious plans within a commercial setting. Fellowships are available in any field of study covered by UK Research and Innovation.
The funding bid supports research evaluating community-level initiatives that prevent or reduce loneliness in the UK. It seeks to assess the health and health inequality impacts of interventions—including community assets, place-based approaches, social skills programs, and virtual communities—focusing specifically on loneliness rather than social isolation, to inform effective population-level strategies.
The BAPRAS Pump Priming Fund offers a single grant each year to support pump priming clinical trial projects in the field of plastic surgery. The aim of the award is to support early feasibility work for a proposed clinical trial in support of a subsequent application for funding from the NIHR or other large funding body.
The Medical Research Council (MRC) provides experimental medicine grants to support academically-led experimental medicine projects that address gaps in current understanding of the causes, progression and treatment of human disease through experimental intervention, or challenge, in humans.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
The funding bid supports the development and clinical validation of improved point-of-care diagnostic devices. It aims to optimise accuracy, usability, and affordability, meet WHO REASSURED criteria, and demonstrate added value over existing tests, with priority for resource-limited settings and high-impact infectious or emergency disease applications.
Applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness and quality of digital mental health interventions that may impact mental health outcomes, including suicide behaviours and serious mental illness.
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities. The overall goal of this NOFO is to identify cancer risks and risk reduction strategies, to identify factors that cause cancer in humans, and to discover and develop mechanisms for cancer prevention and preventive interventions in humans.
This funding opportunity supports clinical trials of orphan products (phases 1–3) for rare diseases with unmet medical needs. It aims to evaluate safety and/or efficacy to support new indications or labeling changes, ultimately increasing approved treatments and advancing innovative, collaborative approaches in rare disease drug development.
Capital grants for UK-registered private sector life sciences companies for large-scale R&D projects that are primarily capital investments and dependent on the grant to proceed.
